SENP6 (NM_001100409) Human Untagged Clone

CAT#: SC316860

SENP6 (untagged)-Human SUMO1/sentrin specific peptidase 6 (SENP6), transcript variant 2



  "NM_001100409" in other vectors (4)

CNY 10,450.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (4)
TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

CNY 4,090.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

CNY 1,280.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

CNY 480.00


SENP6 rabbit polyclonal antibody
    • 25 ul

CNY 800.00
CNY 1,280.00

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Synonyms SSP1; SUSP1
Vector pCMV6 series
Sequence Data
>NCBI ORF sequence for NM_001100409, the custom clone sequence may differ by one or more nucleotides
ATGGCGGCCGGCAAGAGCGGCGGTAGCGCAGGGGAGATTACTTTTCTGGAAGCTTTGGCT
AGATCAGAGTCTAAGAGAGATGGAGGTTTTAAAAATAATTGGAGCTTTGATCATGAAGAA
GAAAGTGAAGGAGATACAGATAAAGATGGGACAAATCTGCTCAGTGTGGATGAAGATGAG
GATTCTGAAACCTCAAAAGGAAAAAAGTTAAATCGTCGATCTGAAATTGTTGCTAATAGC
TCTGGTGAATTCATCTTGAAGACATATGTAAGACGAAACAAGTCTGAAAGTTTTAAAACT
TTGAAAGGCAACCCAATTGGACTTAACATGTTGAGCAACAATAAGAAATTGAGTGAAAAT
ACGCAAAATACGTCATTATGTTCTGGAACTGTAGTTCATGGTAGACGTTTTCATCATGCT
CATGCACAGATACCAGTAGTAAAAACAGCAGCCCAAAGGAAAGAATACCCACCTCATGTC
CAAAAAGTTGAAATTAATCCTGTAAGGTTAAGTCGGCTCCAAGGTGTTGAACGTATAATG
AAGAAAACAGAAGAGTCCGAATCACAAGTGGAGCCTGAAATTAAGAGGAAAGTACAACAG
AAACGACACTGTAGTACCTATCAGCCTACTCCTCCTCTATCTCCTGCTTCAAAAAAATGT
TTAACCCATTTAGAGGATTTGCAAAGAAATTGCAGACAAGCTATTACTTTGAATGAGTCT
ACTGGACCATTATTAAGAACGTCAATTCATCAGAATTCTGGAGGACAGAAGTCACAAAAC
ACAGGATTAACAACCAAGAAGTTTTATGGCAACAATGTGGAAAAGGTTCCAATTGATATT
ATTGTGAATTGTGATGACAGTAAACACACTTATTTACAGACTAATGGAAAAGTCATTTTA
CCTGGGGCAAAAATACCCAAAATCACAAACTTGAAAGAAAGGAAAACAAGTTTGTCAGAC
CTAAATGATCCAATCATTTTGTCCAGTGATGATGATGATGACAACGACAGAACTAACAGA
AGAGAAAGCATATCTCCTCAGCCTGCTGATTCAGCATGTTCTTCCCCTGCACCATCCACT
GGAAAAGTAGAAGCAGCGCTAAATGAAAATACTTGCAGAGCAGAGCGTGAACTACGAAGC
ATTCCAGAAGACTCAGAGTTAAATACAGTTACATTGCCAAGAAAAGCAAGAATGAAAGAC
CAGTTTGGCAATTCTATTATCAACACACCTCTGAAACGTCGTAAAGTGTTTTCTCAAGAA
CCTCCAGATGCTTTAGCTTTAAGCTGCCAAAGTTCCTTTGACAGTGTCATTTTAAACTGT
CGAAGTATACGAGTAGGAACACTCTTCCGGCTGTTAATAGAGCCTGTAATTTTTTGTTTA
GATTTTATCAAGATACAGCTAGACGAACCAGACCATGATCCTGTAGAGATTATATTAAAT
ACCTCTGATCTAACTAAATGTGAATGGTGTAATGTCCGAAAATTACCTGTAGTGTTTCTT
CAAGCAATTCCAGCAGTTTATCAAAAGCTGAGCATCCAACTGCAAATGAATAAGGAGGAT
AAAGTTTGGAATGATTGTAAAGGAGTAAATAAATTAACAAATTTAGAAGAACAATATATA
ATTTTAATTTTTCAAAATGGCCTTGATCCTCCGGCAAATATGGTATTTGAAAGTATCATT
AATGAAATTGGTATAAAGAATAACATCTCCAATTTTTTTGCGAAAATTCCCTTTGAAGAA
GCTAATGGCAGACTTGTTGCCTGTACAAGAACCTATGAAGAGAGCATCAAAGGAAGTTGT
GGGCAAAAGGAAAACAAAATTAAAACTGTATCATTTGAATCTAAAATACAACTTAGAAGC
AAACAAGAATTTCAGTTTTTTGATGAAGAAGAAGAAACTGGAGAAAACCACACCATCTTC
ATTGGCCCAGTAGAAAAGTTGATAGTATATCCACCACCTCCAGCTAAGGGAGGCATCTCT
GTTACCAATGAGGACCTGCACTGTCTAAATGAAGGAGAATTTTTAAATGATGTTATTATA
GACTTTTATTTGAAATACTTGGTGCTTGAAAAACTGAAGAAGGAAGACGCTGACCGAATT
CATATATTCAGTTCTTTTTTCTATAAACGCCTTAATCAGAGAGAGAGGAGAAATCATGAA
ACAACTAATCTGTCAATACAGCAAAAACGGCATGGGAGAGTAAAAACATGGACCCGGCAC
GTAGATATTTTTGAGAAGGATTTTATTTTTGTACCCCTTAATGAAGCTGCACACTGGTTT
TTGGCTGTTGTTTGTTTCCCCGGTTTGGAAAAACCAAAGTATGAACCTAATCCTCATTAC
CATGAAAATGCTGTCATACAGAAATGTTCAACTGTAGAGGACAGTTGTATTTCTTCTTCA
GCCAGTGAAATGGAGAGTTGTTCACAAAACTCTTCTGCCAAGCCTGTAATTAAGAAGATG
CTAAACAAAAAACATTGCATAGCTGTAATTGATTCCAATCCTGGGCAGGAAGAAAGTGAC
CCTCGTTATAAGAGAAACATATGCAGTGTAAAATACAGTGTGAAAAAAATAAATCATACT
GCGAGTGAAAATGAAGAATTCAATAAAGGAGAATCTACATCCCAGAAAGTTGCTGATAGG
ACTAAAAGTGAGAATGGCCTACAGAATGAAAGTTTAAGTTCCACACATCATACAGATGGC
TTAAGCAAAATCAGACTAAACTATAGCGATGAATCACCTGAAGCTGGTAAAATGCTTGAA
GATGAACTCGTCGACTTCTCAGAAGATCAGGATAACCAGGATGATAGCAGTGACGATGGA
TTCCTCGCTGATGACAACTGCAGTTCAGAAATAGGACAGTGGCATTTAAAGCCTACTATC
TGTAAACAACCTTGTATCCTACTTATGGACTCACTCCGAGGCCCTTCTCGGTCAAATGTT
GTCAAAATTTTAAGAGAGTATTTAGAAGTGGAATGGGAAGTTAAAAAAGGAAGCAAAAGA
AGTTTTTCCAAAGATGTTATGAAGGGCTCTAATCCAAAAGTACCACAGCAAAACAACTTC
AGTGACTGTGGTGTATATGTATTGCAGTATGTAGAGAGCTTTTTTGAGAATCCAATTCTC
AGTTTTGAACTACCTATGAATTTGGCAAACTGGTTTCCTCCACCAAGAATGAGAACAAAA
AGAGAAGAAATCCGAAACATAATTCTGAAGCTACAGGAAGATCAGAGCAAAGAGAAAAGA
AAGCATAAGGACACTTACTCAACAGAAGCACCTTTAGGCGAAGGAACAGAACAATATGTC
AATAGTATCTCAGAT
Restriction Sites Please inquire     
ACCN NM_001100409
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_001100409.1, NP_001093879.1
RefSeq Size 6624 bp
RefSeq ORF 3318 bp
Locus ID 26054
UniProt ID Q9GZR1
Protein Families Druggable Genome, Protease
Gene Summary Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1; MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins (Kim et al., 2000 [PubMed 10799485]). SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]
Transcript Variant: This variant (2) lacks an alternate in-frame exon in the 5' coding region, compared to variant 1, resulting in a shorter protein (isoform 2), compared to isoform 1. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on transcript alignments.
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...